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Research in the field of drug metabolism and pharma-
cokinetics (DMPK) has become an essential part of drug
discovery, development, and testing. The research has
received considerable attention over the last few de-
cades. Mass spectrometry (MS) has proven to be an
exceptionally valuable tool that supports all phases of
these enterprises. The rapidly expanding versatility of
modern mass spectrometers and the concomitant qual-
ity of MS-derived information necessitates and justifies
a timely summary of actual knowledge. Precedents are,
for example, in 2002 (“Mass Spectrometry in Drug
Discovery,” D. T. Rossi and M. W. Sinz) and 2005
(“Using Mass Spectrometry for Drug Metabolism Stud-
ies,” W. A. Korfmacher).
The book, Mass Spectrometry in Drug Metabolism and
Pharmacokinetics, based on an American Society for
Mass Spectrometry (ASMS) session, superbly intro-
duces the arena of DMPK and mass spectrometry to a
broad readership, further outlining the importance of
rapid, accurate, and unequivocal identification of target
analytes in drug discovery and development. It con-
tains a large amount of educational information on
DMPK studies in general but also offers a more detailed
description of common challenges, software solutions,
simulation of metabolic reactions, and modern instru-
mental options and possibilities offered by different
ionization modes and analyzers. The book is organized
into 12 separate chapters written by multiple authors, a
fact that led to some content overlap and inconsistency,
although this is evident at a minor level as the accom-
plished and distinguished editorial work takes the fore.
Primarily, the book focuses on the role of liquid chro-
matography (LC) combined with MS (LC-MS) in drug
metabolism (DM) and pharmacokinetics (PK), with spe-
cial attention paid to triple quadrupole/quadrupole–
linear ion trap (QqQ/QqLIT), quadrupole–time-of-flight
(QTOF), and Fourier Transform (FT) ion cyclotron reso-
nance (ICR) as well as Orbitrap mass analyzers. Further-
more, different LC options are discussed and principal
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(J Am Soc Mass Spectrom 2009, 20, R19–R21)alternatives such as desorption ionization techniques
and direct tissue analysis are covered.
The first chapter reports on the “Role of Mass
Spectrometry in Drug Discovery and Development”
and fully accomplishes the goal of introducing the topic
by explaining the general processes of drug discovery
and development, fundamentals of chromatography and
MS, defining the terminology used in MS, explaining
advances in sample preparation techniques, and outlining
principal metabolic pathways. This introduction caters to
a broad readership, including non-specialized clients, and
it serves as an appropriate preparation for the sequel
chapters. The introduction closes with a comprehensive
list of references that is provided to allow distinct further
reading.
The main purpose of Chapter 2, “Quantitative Bio-
analysis in Drug Discovery and Development: Princi-
ples and Applications,” is “to describe the fundamental
process of obtaining pharmacokinetic data derived
from the concentration data” and “to describe the
greatest challenges facing quantitative bioanalysis.”
Here, the reader is provided with salient information to
define the drug’s pharmacokinetic profile in a well-
structured, legible, and illustrated way. Subsequently,
challenges of accurate analyte quantitation from liquids
such as plasma or serum are described, dealing with the
major issue of ion suppression, co-elution, and strate-
gies to circumvent these followed by suggestions on
how to approach the thankless task of isolating and
quantifying target analytes from tissue samples. The
chapter closes with discussions of recent developments
and corresponding FDA requirements regarding the hu-
man microdosing strategy, where the lowest amounts of
(radiolabeled) drug candidates are first used in humans,
resulting in required MS detection limits of commonly
10 pg/mL and thus necessitating analytical instruments
of the utmost sensitivity. This leads to the debate on
the utility of accelerator mass spectrometry (AMS)
and smoothly proceeds into the next chapters that
outline the specific advantages of selected types of
mass spectrometers.
Chapters 3–5 are dedicated to three specific mass
spectrometers—QqQ/QqLIT, QTOF, and FTMS—and re-
ports on their current use as well as their advantages and
disadvantages in DMPK. In Chapter 3, the fundamentals
of quadrupole, QqQ, and QqLIT are well explained to an
extent that perfectly serves the purpose of understanding
the options provided by the instrumental setup (e.g., full
scan, product ion scan, multiple-reaction monitoring, neu-
tral loss scan, or precursor ion scan, and combinations of
these in an information-dependent manner). Selected ex-
amples further substantiate the understanding of the
utility and provide a sound basis for the reader to com-
pare these tools with those of the subsequently presented
instruments.
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Time-of-Flight Mass Spectrometry in Reactive Metabo-
lite Screening,” starting with an introduction to high-
performance LC (HPLC), ultrahigh-performance LC
(UPLC), and the requirements for fast-scanning MS
such as QTOF analyzers. The description of the theory
of TOF-MS and the principal setup of QTOF instru-
ments is, unfortunately, comparably short. The utility
and advantages of this technique, however, are well
illustrated by using selected examples. The focus of
Chapter 5 is the use of FTMS in absorption, distribution,
metabolism, excretion, and toxicology (ADMET) stud-
ies predominantly outlined by means of LIT-FTMS
instruments such as the hybrids composed of linear ion
trap and ICR (LTQ-FT) or Orbitrap (LTQ-Orbitrap). In
contrast to the instruments described in the preceding
chapters, the authors have omitted theoretical consid-
erations and explanations of ICR and Orbitrap physics
but reported on earlier drawbacks of FTMS and the
resulting absence in DMPK studies. The drawbacks of
FTMS include the costly and complex nature of these
instruments, the incompatibility with high LC flow
rates, and so forth, which were overcome with the
development of hybrid instruments and in particular
the Orbitrap mass analyzer that does not require an
expensive superconducting magnet. The advantages of
these FTMS-based systems such as highest mass resolv-
ing power and mass accuracy also in MSn modes are
nicely illustrated by using appropriately selected exam-
ples (e.g., the elimination of interferences in complex
matrices, the generation of valuable information on
elemental compositions of analytes and fragment ions
supporting the characterization of structural features of
detected metabolites, or the subsequent utility of the
mass defect filter approach of data processing as out-
lined in Chapter 6).
Using a simple algorithm, based on the mass defect
of a target drug and related species such as metabolites,
one can remove all ions that fall outside a preset filter
window and thereby significantly simplify LC-MS anal-
yses. This post-acquisition data-mining approach is
described in detail in Chapter 6 and requires high-
resolution MS data and a clear definition of expected
metabolic reactions. Explained and illustrated using
well-chosen examples, the concept of the mass defect
filter (MDF) process is a valuable contribution to the
book and could have been used by several other con-
tributing authors as a reference rather than briefly
describing this option once more.
Chapters 7 and 8 focus on modern options to study
and simulate metabolic reactions using radiolabels and
electrochemistry (EC), respectively. Recent approaches
to increase the sensitivity for 3H or 14C, combined
online as well as offline with mass spectrometric char-
acterization of metabolites, are outlined, discussing the
advantages over earlier methods in appropriate detail
and giving the reader a well-structured insight into the
need and issues of radiolabeled-drug analysis. The
basics and the utility of EC coupled online with MS tosimulate cytochrome P450 enzymatic reactions are re-
ported and explained well with the advantages and
disadvantages illustrated by means of excellent exam-
ples. However, some aspects could have been further
elaborated (perhaps as an additional chapter) such as
the in vitro metabolism approach as well as the fact that
EC occasionally yields products other than those ob-
served under in vivo/in vitro conditions and also might
fail to simulate the metabolism of selected compounds.
Further tools to support the characterization of metab-
olites are described in Chapter 9, where H/D-exchange
was conducted online in LC-MS/MS analyses. The infor-
mation on exchangeable (mobile) hydrogens and subse-
quent dissociation processes allows differentiating hy-
droxylamine and N-oxide derivatives, which adds
another valuable option to study and identify new
drugs and respective degradation products.
In Chapter 10, the need for high-throughput screening
in drug discovery and development is emphasized and
the option to accelerate sample analysis by turbulent flow
liquid chromatography with considerably reduced sam-
ple preparation effort is described. Theory and application
are well balanced and illustrated, outlining important
questions and issues such as ion suppression effects,
detection limits, and carryover effects, for example.
The book closes with two chapters on desorption
ionization techniques and their applications. In Chapter
11, the utility of matrix-assisted laser desorption ioniza-
tion (MALDI) and direct ionization on silicon (DIOS)
for the quantitative determination of target analytes is
discussed, particularly in combination with QqQ MS
instruments. The comparison with conventional electro-
spray ionization-MS/MS (ESI-MS/MS) demonstrates
not only the significantly higher throughput of samples
when using desorption ionization rather than ESI, but
also the necessity to ensure high and reproducible
crystal quality and homogeneity of spots for MALDI
measurements and the great care of sample and silicon-
chip handling in the case of matrix-free DIOS analysis.
Finally, MALDI imaging MS for direct tissue analysis of
pharmaceuticals is described in Chapter 12, highlight-
ing the great potential of this technique and, at the same
time, its very early stage of development. Basic princi-
ples including sample (tissue) preparation and selection
of adequate matrices are explained well and the consid-
erations regarding ion-imaging, laser diameter, crystal
size, and relative response of analytes, for example, are
discussed in a well-balanced manner.
Overall, Mass Spectrometry in Drug Metabolism and
Pharmacokinetics is a valuable and interesting resource
for a broad readership, including scientists starting to
work in DMPK as well as undergraduate and graduate
students getting involved in drug discovery and charac-
terization by means of MS. A wealth of important infor-
mation is provided and all of the contributing authors
have done an excellent job in explaining and outlining
particular aspects of MS-based tools in DMPK, although
(to some extent) their affiliation with instrument vendors
was inevitably evident. The only aspect that I missed
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The class of peptide hormone-based drugs, for instance,
represents an important and constantly increasing class of
therapeutics and it would have been interesting to read
about the particular challenges that these compounds
raise in DMPK and the strategies to approach them usingmass spectrometry. In addition, more information on the
potential utility of ion mobility MS could have been
included. The techniquewas brieflymentioned in Chapter
4 but unfortunately not discussed in any detail. Neverthe-
less, relatively speaking, these are very minor criticisms
and the book is highly recommended reading.
